JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, cilt.76, sa.2, ss.443-450, 2021 (SCI-Expanded)
Background: Stenotrophomonas maltophilia is a Gram-negative bacterium resistant to several antibiotics and its prevalence in cystic fibrosis (CF) patients is increasing.